The BioNTech SE (BNTX) revenue growth is (54.1%), which is lower than the industry median of 13.4% and the 5-year historical average of 1,061.7%.
The BioNTech SE (BNTX) operating income growth is N/A, compared to the industry median of 1.1% and the 5-year historical average of 117.8%.
The BioNTech SE (BNTX) EPS growth is N/A, compared to the industry median of (20.2%) and the 5-year historical average of 5,122.5%.
The BioNTech SE (BNTX) Free Cash Flow growth is (79.0%), compared to the industry median of (1.2%) and the 5-year historical average of 179.6%.